Compounds
Evidence-based profiles for 107 compounds
Hot & New
Weekly snapshot of compounds with the strongest recent research momentum.
Hot This Week
#1
Tirzepatide
56 recent studies · 25 high-tier · latest 2026
#2
GHK-Cu
58 recent studies · latest 2026
#3
MOTS-c
48 recent studies · 1 high-tier · latest 2026
#4
Creatine Monohydrate
31 recent studies · 10 high-tier · latest 2026
#5
NAD+ Precursors
41 recent studies · 2 high-tier · latest 2026
#6
Semaglutide
29 recent studies · 6 high-tier · latest 2026
New & Emerging
No emerging compounds yet.
107 compounds
Tirzepatide
81Dual GLP-1/GIP receptor agonist; GIP agonism sensitizes adipocytes and augments incretin effect beyond GLP-1 alone
Evidence
Strong evidence
Safety
Safety unknown
Creatine Monohydrate
78Increases intracellular phosphocreatine, enhancing ATP resynthesis during high-intensity activity
Evidence
Strong evidence
Safety
Safety unknown
Retatrutide
78Triple GLP-1/GIP/glucagon receptor agonist; adds hepatic fat mobilization and increased energy expenditure to GLP-1/GIP incretin effects
Evidence
Strong evidence
Safety
Safety unknown
Semaglutide
78GLP-1 receptor agonist: delays gastric emptying, suppresses appetite via hypothalamic signaling, stimulates glucose-dependent insulin secretion
Evidence
Strong evidence
Safety
Safety unknown
Survodutide
77Dual GLP-1/glucagon receptor agonist; adds hepatic fat mobilization and increased energy expenditure to GLP-1 satiety effects
Evidence
Strong evidence
Safety
Safety unknown
Modafinil
76Weak DAT inhibition raises synaptic dopamine; activates orexin/hypocretin neurons; increases histamine and NE
Evidence
Strong evidence
Safety
Safety unknown
HGH
76Binds GH receptor on hepatocytes → IGF-1 production; directly stimulates lipolysis in adipose; promotes nitrogen retention and tissue repair via IGF-1/mTOR/PI3K
Evidence
Strong evidence
Safety
Safety unknown
Citrulline Malate
76L-citrulline converts to arginine → NO via NOS → vasodilation; malate fuels Krebs cycle ATP synthesis and accelerates ammonia clearance
Evidence
Strong evidence
Safety
Safety unknown
Fish Oil
76EPA and DHA compete with arachidonic acid for COX/LOX enzymes, shifting eicosanoid production toward anti-inflammatory SPMs; DHA incorporates into cell membranes affecting fluidity and receptor function
Evidence
Strong evidence
Safety
Safety unknown
Ashwagandha
75Withanolides modulate HPA axis, reduce cortisol, potentiate GABA-A signaling, and inhibit NF-kB inflammation
Evidence
Strong evidence
Safety
Safety unknown
Vitamin D3
75Precursor to calcitriol; binds vitamin D receptor (nuclear receptor) in all cell types; regulates calcium homeostasis, immunity, muscle function, and expression of 200+ genes
Evidence
Moderate evidence
Safety
Safety unknown
Beta-Alanine
74Rate-limiting carnosine precursor; muscle carnosine buffers intramuscular H+ ions during high-intensity glycolytic activity
Evidence
Moderate evidence
Safety
Safety unknown
Cerebrolysin
74Porcine brain peptide mixture with neurotrophic factor-like activity; activates BDNF/NGF signaling pathways; promotes neuroplasticity, neuronal survival, and synaptogenesis
Evidence
Moderate evidence
Safety
Safety unknown
Magnesium Glycinate
73NMDA receptor voltage-dependent block, calcium channel regulation, HPA axis modulation, ATP synthesis cofactor, melatonin precursor support
Evidence
Moderate evidence
Safety
Safety unknown
L-Theanine
73GABA-A positive allosteric modulation, NMDA/AMPA antagonism, alpha-wave induction, catecholamine modulation
Evidence
Moderate evidence
Safety
Safety unknown
CoQ10
73Electron shuttle in mitochondrial ETC (complex I-III); lipophilic antioxidant protecting cell membranes; regenerates vitamins C and E; replenishes statin-depleted CoQ10
Evidence
Moderate evidence
Safety
Safety unknown
Berberine
72AMPK activator; inhibits complex I of mitochondrial respiratory chain (similar to metformin); reduces hepatic gluconeogenesis; activates GLUT4 translocation; reduces intestinal glucose absorption
Evidence
Moderate evidence
Safety
Safety unknown
Anavar
72Oral DHT-derived anabolic; binds AR in muscle/bone without aromatization; high anabolic-to-androgenic ratio; FDA-approved for wasting conditions
Evidence
Moderate evidence
Safety
Safety unknown
Testosterone Cypionate
72Binds androgen receptor as full agonist; activates muscle, bone, erythropoiesis, and CNS AR programs; aromatizes to estradiol via CYP19A1
Evidence
Moderate evidence
Safety
Safety unknown
PT-141
71MC3R and MC4R agonist in the hypothalamus; activates central arousal pathways independent of vascular mechanisms
Evidence
Moderate evidence
Safety
Safety unknown
Tesamorelin
71Stabilized GHRH analog binding pituitary GHRH receptors; stimulates GH/IGF-1 production, reducing visceral fat via lipolysis
Evidence
Moderate evidence
Safety
Safety unknown
NAD+ Precursors
70Orally bioavailable NAD+ precursors; NR converts to NMN then NAD+; NMN converts directly to NAD+; elevates NAD+ for sirtuin activation, PARP DNA repair, and mitochondrial biogenesis
Evidence
Moderate evidence
Safety
Safety unknown
Methylene Blue
70Alternative mitochondrial electron carrier in complex I-IV chain; improves oxidative phosphorylation; MAO inhibitor; antioxidant at low doses; hormetic dose-response
Evidence
Moderate evidence
Safety
Safety unknown
Tongkat Ali
68Reduces SHBG and cortisol to free more testosterone; possible direct LH/FSH stimulation; eurycomanone (active quassinoid) drives most studied effects
Evidence
Moderate evidence
Safety
Safety unknown
Alpha-GPC
68Rapidly absorbed choline donor; crosses BBB and upregulates acetylcholine synthesis in cortical neurons
Evidence
Moderate evidence
Safety
Safety unknown
Phenylpiracetam
68Phenyl-substituted piracetam; enhances dopamine and norepinephrine activity; increases NMDA/AMPA receptor density; stimulant and cognitive-enhancing properties
Evidence
Moderate evidence
Safety
Safety unknown
Noopept
67Dipeptide nootropic; metabolizes to cycloprolylglycine; upregulates NGF and BDNF; modulates AMPA and NMDA receptors; anxiolytic-nootropic profile
Evidence
Moderate evidence
Safety
Safety unknown
MOTS-c
67Mitochondria-to-nucleus retrograde signaling via AMPK and AICAR; improves insulin sensitivity, metabolic flexibility, and exercise capacity
Evidence
Moderate evidence
Safety
Safety unknown
LGD-4033
67High-affinity selective AR agonist; near-complete receptor occupancy at low doses produces significant muscle anabolism with moderate bone activation
Evidence
Moderate evidence
Safety
Safety unknown
SS-31
67Selectively partitions to inner mitochondrial membrane via cardiolipin binding; stabilizes cristae, reduces ROS, and restores ATP production efficiency
Evidence
Moderate evidence
Safety
Safety unknown
Nandrolone Phenylpropionate
67Highly anabolic 19-nor androgen; partial AR agonist with progestogenic activity; minimal aromatization; high anabolic-to-androgenic ratio via tissue-specific AR binding
Evidence
Moderate evidence
Safety
Safety unknown
Ostarine
67Selective AR agonist with tissue selectivity for muscle and bone over prostate and sebaceous glands; anabolic without full androgenic activity
Evidence
Moderate evidence
Safety
Safety unknown
NSI-189
67Stimulates hippocampal neurogenesis via unknown mechanism; increases stem cell proliferation and differentiation; demonstrated hippocampal volume increase on MRI in Phase I
Evidence
Moderate evidence
Safety
Safety unknown
Lion's Mane
67Hericenones and erinacines stimulate NGF and BDNF synthesis, promoting neuroplasticity, myelination, and neuroprotection
Evidence
Moderate evidence
Safety
Safety unknown
9-MBC
67MAO-A/B inhibitor; promotes dopaminergic neuron proliferation and differentiation; neuroprotective in MPTP Parkinson's models; increases BDNF and GDNF expression (preclinical only)
Evidence
Moderate evidence
Safety
Safety unknown
MK-677
66Ghrelin receptor (GHSR-1a) agonist; stimulates pulsatile GH release from anterior pituitary; elevates IGF-1 without suppressing endogenous GH axis
Evidence
Moderate evidence
Safety
Safety unknown
Dihexa
66Potentiates HGF/c-Met receptor signaling, dramatically enhancing synaptogenesis, dendritic spine density, and hippocampal LTP
Evidence
Moderate evidence
Safety
Safety unknown
GHK-Cu
65Activates collagen synthesis and wound healing genes; broad anti-inflammatory and antioxidant effects via Nrf2 and NF-κB pathways
Evidence
Moderate evidence
Safety
Safety unknown
CJC-1295
65GHRH receptor agonist on pituitary somatotrophs; stimulates pulsatile GH release and downstream IGF-1 production
Evidence
Moderate evidence
Safety
Safety unknown
Primobolan
64DHT-derived anabolic; binds AR without aromatization; no estrogenic activity; anabolic with low androgenicity; notable immune-modulatory effects
Evidence
Moderate evidence
Safety
Safety unknown
BPC-157
64Upregulates VEGF and GH receptors; activates FAK-paxillin tendon repair pathway; modulates NO-cGMP system
Evidence
Moderate evidence
Safety
Safety unknown
TB-500
64Sequesters G-actin, promotes cell migration and angiogenesis via eNOS upregulation and anti-inflammatory cytokine modulation
Evidence
Moderate evidence
Safety
Safety unknown
Cardarine
63PPARδ/β agonist; transcriptionally activates fatty acid oxidation genes (CPT1, ABCA1) in skeletal muscle; dramatically increases mitochondrial biogenesis and fat burning
Evidence
Moderate evidence
Safety
Safety unknown
Ipamorelin
63Ghrelin mimetic at GHS-R1a receptors; amplifies GH pulse without raising cortisol or prolactin
Evidence
Moderate evidence
Safety
Safety unknown
RAD-140
61Potent selective AR agonist; high muscle:prostate anabolic ratio; also activates neuroprotective AR pathways in brain
Evidence
Moderate evidence
Safety
Safety unknown
YK-11
57Partial AR agonist with structural similarity to DHT; upregulates Follistatin to inhibit myostatin, potentially removing the ceiling on muscle hypertrophy
Evidence
Moderate evidence
Safety
Safety unknown
Masteron
41DHT-derived androgen with intrinsic anti-estrogenic activity; no aromatization; competes with estrogen at receptor level; moderate AR agonist with hardening/drying cosmetic effects
Evidence
Early evidence
Safety
Safety unknown
AOD-9604
N/ABeta-3 adrenergic receptor agonism increases lipolysis in adipocytes; mimics GH lipolytic domain without activating somatotropic axis; may inhibit lipogenesis
Evidence
No score yet
Safety
Safety unknown
Acarbose
N/ACompetitive inhibitor of alpha-glucosidase and pancreatic alpha-amylase in small intestine; delays breakdown of complex carbs to glucose; reduces postprandial glucose spike by 30-50%; modifies gut microbiome
Evidence
No score yet
Safety
Safety unknown
Acetyl-L-Carnitine
N/AAcetyl donor for acetylcholine synthesis; mitochondrial membrane repair; NGF signaling; carnitine palmitoyltransferase support for beta-oxidation
Evidence
No score yet
Safety
Safety unknown
Alpha-Lipoic Acid
N/AMitochondrial PDH/KGDH cofactor; recycles vitamins C, E, Q10, and glutathione; activates AMPK; Nrf2 induction; inhibits NF-kB; chelates heavy metals
Evidence
No score yet
Safety
Safety unknown
Anastrozole
N/AReversible competitive inhibitor of aromatase (CYP19A1); blocks conversion of testosterone → estradiol; reduces circulating estrogen by 70-80% in men
Evidence
No score yet
Safety
Safety unknown
Andarine (S4)
N/AFull agonist at androgen receptor in muscle/bone; partial agonist at AR in prostate and eye; promotes nitrogen retention, protein synthesis; fat oxidation via beta-AR upregulation
Evidence
No score yet
Safety
Safety unknown
Bacopa Monnieri
N/ABacosides inhibit acetylcholinesterase; induce BDNF and dendrite branching; antioxidant via SOD/CAT induction; serotonin 5-HT3 antagonism; cortisol reduction
Evidence
No score yet
Safety
Safety unknown
Boron
N/AInhibits SHBG production in liver; activates CYP27B1 for vitamin D conversion; modulates sex steroid binding; supports bone calcium retention
Evidence
No score yet
Safety
Safety unknown
Boswellia
N/AAKBA directly inhibits 5-lipoxygenase (5-LOX), preventing leukotriene B4/C4/D4 synthesis; reduces inflammatory infiltrate without COX inhibition; MMP inhibition in cartilage
Evidence
No score yet
Safety
Safety unknown
Bromantane
N/AUpregulates AADC (dopa decarboxylase) gene expression; increases dopamine and serotonin synthesis capacity; non-releasing, non-reuptake mechanism; heat shock protein induction
Evidence
No score yet
Safety
Safety unknown
Clenbuterol
N/ABeta-2 adrenergic receptor agonist; increases cAMP via Gs → activates PKA → phosphorylates HSL (hormone-sensitive lipase) → lipolysis; thermogenic via uncoupled mitochondrial respiration
Evidence
No score yet
Safety
Safety unknown
Cordyceps
N/ACordycepin (adenosine analog) modulates adenosine receptors; adenosine 5'-monophosphate increases ATP availability; AMPK activation drives mitochondrial biogenesis
Evidence
No score yet
Safety
Safety unknown
Curcumin
N/AIKKβ inhibition → NF-kB nuclear translocation block; COX-2 and 5-LOX inhibition; Nrf2 activation; AMPK activation; reduces TNF-alpha, IL-1beta, IL-6
Evidence
No score yet
Safety
Safety unknown
Enclomiphene
N/ABlocks ER-alpha in hypothalamus and pituitary, reducing estrogen negative feedback; pulsatile GnRH/LH/FSH increase drives testicular testosterone production and spermatogenesis
Evidence
No score yet
Safety
Safety unknown
Ephedrine
N/AIndirect sympathomimetic (releases NE/E from presynaptic terminals); direct alpha and beta adrenergic agonism; mild MAO inhibition; increases thermogenesis, lipolysis, bronchodilation
Evidence
No score yet
Safety
Safety unknown
Epithalon
N/ATelomerase activation via epigenetic (DNA methylation) changes; pineal gland stimulation increasing melatonin; antioxidant enzyme induction; p53/Bcl-2 apoptosis modulation
Evidence
No score yet
Safety
Safety unknown
Fasoracetam
N/AUpregulates mGluR2/3 (Group II metabotropic glutamate receptors); GABA-B receptor agonism (anxiolytic); choline uptake facilitation; reverses mGluR downregulation from stimulant use
Evidence
No score yet
Safety
Safety unknown
Fisetin
N/ABcl-2/Bcl-xL/Bcl-W inhibitor (senolytic) — selectively kills senescent cells dependent on these anti-apoptotic proteins; Nrf2 activation; SIRT1 activation; mTOR inhibition
Evidence
No score yet
Safety
Safety unknown
GHRP-6
N/AGhrelin receptor (GHSR-1a) agonist in pituitary and hypothalamus; amplifies GHRH-driven GH pulse; stimulates appetite via hypothalamic NPY/AgRP neurons
Evidence
No score yet
Safety
Safety unknown
Ginkgo Biloba
N/APAF (platelet-activating factor) antagonism; inhibits phosphodiesterase → increased cGMP; free radical scavenging (flavonoids); inhibits EAA receptor-mediated excitotoxicity (bilobalide)
Evidence
No score yet
Safety
Safety unknown
Glycine
N/AInhibitory glycine receptor agonist; NMDA co-agonist; collagen precursor; glutathione precursor via GCL; reduces core body temperature
Evidence
No score yet
Safety
Safety unknown
Huperzine A
N/AReversible acetylcholinesterase inhibitor (IC50 ~74nM); NMDA antagonist; upregulates NGF; protects against beta-amyloid neurotoxicity
Evidence
No score yet
Safety
Safety unknown
L-Arginine
N/ASubstrate for eNOS, iNOS, nNOS → NO synthesis → cGMP → vasodilation; stimulates pituitary GH release; precursor for ornithine/polyamine synthesis; urea cycle component
Evidence
No score yet
Safety
Safety unknown
L-Glutamine
N/APrimary fuel for enterocytes and lymphocytes; precursor for glutathione; maintains tight junction integrity; nitrogen transporter
Evidence
No score yet
Safety
Safety unknown
L-Tyrosine
N/ACatecholamine synthesis precursor (DOPA decarboxylase pathway); thyroid hormone precursor; competes for large neutral amino acid transporter at BBB
Evidence
No score yet
Safety
Safety unknown
Liothyronine (T3)
N/ATR-alpha and TR-beta nuclear receptor agonist → increased mitochondrial uncoupling proteins → thermogenesis; upregulates beta-adrenergic receptors; increases Na+/K+-ATPase expression
Evidence
No score yet
Safety
Safety unknown
Maca
N/AMacamides inhibit fatty acid amide hydrolase (FAAH), elevating endocannabinoids; glucosinolates converted to isothiocyanates; monoamine modulation
Evidence
No score yet
Safety
Safety unknown
Magnesium L-Threonate
N/AUniquely elevates cerebrospinal fluid and synaptic magnesium; increases synaptic density via NMDA receptor modulation; activates PKA/PKC signaling for synaptic plasticity
Evidence
No score yet
Safety
Safety unknown
Melanotan II
N/ANon-selective melanocortin receptor agonist (MC1-4R); MC1R drives melanogenesis; MC3R/MC4R drive libido, appetite suppression, and pro-erectile pathways in hypothalamus
Evidence
No score yet
Safety
Safety unknown
Metformin
N/AAMPK activation via complex I inhibition; mTOR inhibition downstream; NF-kB suppression; GLP-1 secretion enhancement; gut microbiome modification (increases Akkermansia)
Evidence
No score yet
Safety
Safety unknown
N-Acetyl Cysteine
N/ACysteine donor for glutathione synthesis; direct thiol antioxidant; mucolytic via disulfide bond cleavage; modulates glutamate signaling via cystine-glutamate antiporter
Evidence
No score yet
Safety
Safety unknown
Nandrolone Decanoate
N/AAR agonist with lower DHT conversion; progestogen receptor agonism; increases collagen synthesis (II and III); stimulates EPO; IGF-1 upregulation; glucocorticoid antagonism
Evidence
No score yet
Safety
Safety unknown
Nattokinase
N/ADirect fibrin degradation (cleaves Bβ chain); activates tissue plasminogen activator (tPA) and urokinase; degrades PAI-1; reduces blood viscosity and platelet aggregation
Evidence
No score yet
Safety
Safety unknown
Panax Ginseng
N/AGinsenosides activate glucocorticoid receptors, modulate NO production, inhibit neuroinflammation, enhance ACh signaling, support HPG axis via LH stimulation
Evidence
No score yet
Safety
Safety unknown
Phosphatidylserine
N/AStructural membrane phospholipid; activates PKC (cell signaling); inhibits cortisol release via HPA axis; supports acetylcholine and dopamine release
Evidence
No score yet
Safety
Safety unknown
Polygala Tenuifolia
N/ABDNF induction via TrkB receptor; hippocampal neurogenesis promotion; AChE inhibition; sigma-1 receptor modulation; cAMP/CREB pathway activation
Evidence
No score yet
Safety
Safety unknown
Psilocybin
N/A5-HT2A full agonist in PFC, DMN, and limbic system; increases synaptic density (rapid, AMPA-mediated); Default Mode Network (DMN) disruption; neuroplasticity via BDNF and TRKB
Evidence
No score yet
Safety
Safety unknown
Pterostilbene
N/ASIRT1 activator (more potent than resveratrol); AMPK activation; superior BBB penetration; NF-kB inhibition; PPARα activation for fat oxidation; BDNF upregulation
Evidence
No score yet
Safety
Safety unknown
Quercetin
N/ABcl-2/Bcl-xL inhibitor (senolytic); AMPK activator; SIRT1 activator; zinc ionophore; NF-kB inhibitor; 5-lipoxygenase and COX inhibitor; mast cell stabilizer
Evidence
No score yet
Safety
Safety unknown
Rapamycin
N/AFKBP12 binding → mTORC1 inhibition → reduced protein synthesis, increased autophagy, reduced senescence-associated secretory phenotype (SASP), improved lysosomal function
Evidence
No score yet
Safety
Safety unknown
Resveratrol
N/ASIRT1 deacetylase activation (caloric restriction mimetic); AMPK activation; NF-kB inhibition; eNOS upregulation; autophagy induction; aromatase inhibition
Evidence
No score yet
Safety
Safety unknown
Rhodiola Rosea
N/AInhibits MAO-A/B (mild); modulates stress kinases (JNK, AMPK); upregulates SDF-1/HSP70 stress proteins; increases serotonin, dopamine, norepinephrine availability
Evidence
No score yet
Safety
Safety unknown
S-23
N/AFull agonist at AR in muscle and bone; near-complete LH/FSH suppression via hypothalamic/pituitary AR activation; partial agonist in prostate; no aromatization
Evidence
No score yet
Safety
Safety unknown
SR9009
N/ARev-Erbα/β nuclear receptor agonist; represses BMAL1/CLOCK circadian transcription; upregulates mitochondrial biogenesis and fatty acid oxidation genes; suppresses gluconeogenesis
Evidence
No score yet
Safety
Safety unknown
Schisandra
N/ASchisandrins modulate NF-kB and Nrf2 pathways; induce CYP3A4/CYP2C19; hepatoprotective via antioxidant induction; HPA axis normalization
Evidence
No score yet
Safety
Safety unknown
Selank
N/AEnkephalinase inhibition increases endogenous enkephalins; GABA-A modulation without direct binding; BDNF induction; IL-6/interferon modulation; serotonin normalization
Evidence
No score yet
Safety
Safety unknown
Semax
N/ABDNF/CNTF upregulation in hippocampus; D-Asp-HFP sequence binds melanocortin MC4R; modulates dopaminergic and serotonergic systems; anti-inflammatory via IL-6 reduction
Evidence
No score yet
Safety
Safety unknown
Sermorelin
N/AGHRH receptor agonist in anterior pituitary somatotrophs; increases cAMP via Gs-coupled receptor; amplifies pulsatile GH release; preserves hypothalamic-pituitary axis
Evidence
No score yet
Safety
Safety unknown
Spermidine
N/AInhibits EP300 acetyltransferase → Nrf2 and LC3 deacetylation → autophagy induction; eIF5A hypusination for translation of specific proteins; anti-inflammatory via NF-kB suppression
Evidence
No score yet
Safety
Safety unknown
Stanozolol
N/AAR agonist with DHT backbone; potent SHBG competitor; displaces testosterone from SHBG increasing free T; C17-alpha alkylated (oral) for oral bioavailability causing hepatotoxicity
Evidence
No score yet
Safety
Safety unknown
Tadalafil
N/ASelective PDE5 inhibitor; prevents cGMP degradation in vascular smooth muscle → eNOS-derived NO maintains vasodilation → sustained vasodilation in penile corpus cavernosum, pulmonary vasculature, prostate
Evidence
No score yet
Safety
Safety unknown
Taurine
N/AOsmoregulation, membrane stabilization, mitochondrial quality control, GABA-A modulation, antioxidant via bile salt conjugation
Evidence
No score yet
Safety
Safety unknown
Testosterone Enanthate
N/ABinds androgen receptor; drives muscle protein synthesis via mTOR/PI3K/Akt; inhibits glucocorticoid receptors; erythropoietin stimulation; aromatizes to estradiol
Evidence
No score yet
Safety
Safety unknown
Testosterone Propionate
N/AEsterified testosterone cleaved by esterases → free testosterone; identical mechanism to other testosterone esters; ester length determines release rate and half-life only
Evidence
No score yet
Safety
Safety unknown
Thymosin Alpha-1
N/ATLR2/9 agonism activates dendritic cells; T-cell differentiation (Th1 skew) via IL-12/IFN-γ; NK cell maturation; upregulates MHC class I expression on tumor cells
Evidence
No score yet
Safety
Safety unknown
Trenbolone Acetate
N/AHighly potent AR agonist (5x testosterone affinity); direct IGF-1 upregulation; glucocorticoid receptor competition; does not aromatize; progestogenic activity
Evidence
No score yet
Safety
Safety unknown
Urolithin A
N/ASelective mitophagy induction via PINK1/Parkin pathway; upregulates mitochondrial biogenesis via PGC-1alpha; reduces IL-6, TNF-alpha, CRP; extends lifespan in C. elegans, rodents
Evidence
No score yet
Safety
Safety unknown
Vitamin C
N/ACollagen prolyl and lysyl hydroxylase cofactor; reduces ferric to ferrous iron for absorption; recycles oxidized glutathione and vitamin E; supports catecholamine synthesis
Evidence
No score yet
Safety
Safety unknown
Vitamin K2
N/ACofactor for gamma-glutamyl carboxylase; activates MGP (prevents arterial calcification) and osteocalcin (bone mineralization, glucose metabolism)
Evidence
No score yet
Safety
Safety unknown
Zinc
N/ACofactor for >300 enzymes; 5α-reductase and aromatase inhibition; androgen receptor signaling; thymulin production for T-cell maturation
Evidence
No score yet
Safety
Safety unknown